FARALLON CAPITAL MANAGEMENT, L.L.C. Diversified Active

Location: San Francisco, CA

CIK: 0000909661 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $16.63B

Holdings (136)

IQV IQVIA HLDGS INC 4.4%
Value $724M Shares 4,043,506 Share Price $179.17 Est. Cost/Share — Unrealized @ Report Date —
GOOG ALPHABET INC 3.8%
Value $633M Shares 361,094 Share Price $1751.88 Est. Cost/Share — Unrealized @ Report Date —
TMUS T-MOBILE US INC 3.2%
Value $533M Shares 3,949,181 Share Price $134.85 Est. Cost/Share — Unrealized @ Report Date —
TMO THERMO FISHER SCIENTIFIC INC 3.1%
Value $519M Shares 1,114,248 Share Price $465.78 Est. Cost/Share — Unrealized @ Report Date —
SPY SPDR S&P 500 ETF TR 3.1%
Value $510M Shares 1,365,000 Share Price $373.88 Est. Cost/Share — Unrealized @ Report Date —
V VISA INC 2.9%
Value $487M Shares 2,228,104 Share Price $218.73 Est. Cost/Share — Unrealized @ Report Date —
AON AON PLC 2.9%
Value $480M Shares 2,271,514 Share Price $211.27 Est. Cost/Share — Unrealized @ Report Date —
BSX BOSTON SCIENTIFIC CORP 2.9%
Value $476M Shares 13,238,319 Share Price $35.95 Est. Cost/Share — Unrealized @ Report Date —
FIS FIDELITY NATL INFORMATION SV 2.7%
Value $445M Shares 3,149,118 Share Price $141.46 Est. Cost/Share — Unrealized @ Report Date —
ARMK ARAMARK 2.6%
Value $424M Shares 11,023,949 Share Price $38.48 Est. Cost/Share — Unrealized @ Report Date —
CNC CENTENE CORP DEL 2.5%
Value $411M Shares 6,850,000 Share Price $60.03 Est. Cost/Share — Unrealized @ Report Date —
ELV ANTHEM INC 2.5%
Value $409M Shares 1,275,000 Share Price $321.09 Est. Cost/Share — Unrealized @ Report Date —
MSFT MICROSOFT CORP 2.4%
Value $391M Shares 1,758,168 Share Price $222.42 Est. Cost/Share — Unrealized @ Report Date —
WAB WABTEC 2.2%
Value $366M Shares 4,997,371 Share Price $73.20 Est. Cost/Share — Unrealized @ Report Date —
— XILINX INC 2.2%
Value $362M Shares 2,556,000 Share Price $141.77 Est. Cost/Share — Unrealized @ Report Date —
CHTR CHARTER COMMUNICATIONS INC N 2.2%
Value $362M Shares 546,931 Share Price $661.55 Est. Cost/Share — Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 2.1%
Value $351M Shares 2,246,900 Share Price $156.24 Est. Cost/Share — Unrealized @ Report Date —
NYT NEW YORK TIMES CO 2.0%
Value $339M Shares 6,545,329 Share Price $51.77 Est. Cost/Share — Unrealized @ Report Date —
— ACCELERON PHARMA INC 2.0%
Value $333M Shares 2,600,000 Share Price $127.94 Est. Cost/Share — Unrealized @ Report Date —
RTX RAYTHEON TECHNOLOGIES CORP 2.0%
Value $325M Shares 4,542,306 Share Price $71.51 Est. Cost/Share — Unrealized @ Report Date —
META FACEBOOK INC 1.9%
Value $315M Shares 1,154,005 Share Price $273.16 Est. Cost/Share — Unrealized @ Report Date —
CRM SALESFORCE COM INC 1.9%
Value $314M Shares 1,409,045 Share Price $222.53 Est. Cost/Share — Unrealized @ Report Date —
— TIFFANY & CO NEW 1.8%
Value $301M Shares 2,287,000 Share Price $131.45 Est. Cost/Share — Unrealized @ Report Date —
SHW SHERWIN WILLIAMS CO 1.7%
Value $286M Shares 389,366 Share Price $734.91 Est. Cost/Share — Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 1.7%
Value $278M Shares 6,000,000 Share Price $46.40 Est. Cost/Share — Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 1.6%
Value $273M Shares 3,000,000 Share Price $90.93 Est. Cost/Share — Unrealized @ Report Date —
AVGO BROADCOM INC 1.6%
Value $273M Shares 622,995 Share Price $437.85 Est. Cost/Share — Unrealized @ Report Date —
BX BLACKSTONE GROUP INC 1.5%
Value $252M Shares 3,891,886 Share Price $64.81 Est. Cost/Share — Unrealized @ Report Date —
EXEL EXELIXIS INC 1.3%
Value $221M Shares 11,000,000 Share Price $20.07 Est. Cost/Share — Unrealized @ Report Date —
— NEW ORIENTAL ED & TECHNOLOGY 1.3%
Value $214M Shares 1,154,300 Share Price $185.81 Est. Cost/Share — Unrealized @ Report Date —
— SLACK TECHNOLOGIES INC 1.2%
Value $207M Shares 4,912,300 Share Price $42.24 Est. Cost/Share — Unrealized @ Report Date —
WTW WILLIS TOWERS WATSON PLC LTD 1.2%
Value $203M Shares 962,500 Share Price $210.68 Est. Cost/Share — Unrealized @ Report Date —
— INPHI CORP 1.2%
Value $199M Shares 1,239,800 Share Price $160.47 Est. Cost/Share — Unrealized @ Report Date —
BABA ALIBABA GROUP HLDG LTD 1.2%
Value $199M Shares 853,300 Share Price $232.73 Est. Cost/Share — Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 1.2%
Value $192M Shares 875,000 Share Price $219.64 Est. Cost/Share — Unrealized @ Report Date —
HLT HILTON WORLDWIDE HLDGS INC 1.1%
Value $183M Shares 1,640,437 Share Price $111.26 Est. Cost/Share — Unrealized @ Report Date —
— QIAGEN NV 1.0%
Value $172M Shares 3,256,771 Share Price $52.85 Est. Cost/Share — Unrealized @ Report Date —
TRU TRANSUNION 1.0%
Value $172M Shares 1,734,082 Share Price $99.22 Est. Cost/Share — Unrealized @ Report Date —
ASND ASCENDIS PHARMA A/S 1.0%
Value $167M Shares 1,000,000 Share Price $166.78 Est. Cost/Share — Unrealized @ Report Date —
HWM HOWMET AEROSPACE INC 0.8%
Value $140M Shares 4,891,479 Share Price $28.54 Est. Cost/Share — Unrealized @ Report Date —
— MAXIM INTEGRATED PRODS INC 0.8%
Value $137M Shares 1,542,400 Share Price $88.65 Est. Cost/Share — Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.8%
Value $130M Shares 2,275,000 Share Price $57.20 Est. Cost/Share — Unrealized @ Report Date —
ABBV ABBVIE INC 0.7%
Value $123M Shares 1,150,000 Share Price $107.15 Est. Cost/Share — Unrealized @ Report Date —
— AMYRIS INC 0.6%
Value $108M Shares 17,500,000 Share Price $6.18 Est. Cost/Share — Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 0.6%
Value $102M Shares 600,000 Share Price $170.49 Est. Cost/Share — Unrealized @ Report Date —
— MOMO INC 0.6%
Value $93.46M Shares 110,077,000 Share Price $0.85 Est. Cost/Share — Unrealized @ Report Date —
PCG PG&E CORP 0.5%
Value $90.86M Shares 7,292,042 Share Price $12.46 Est. Cost/Share — Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.5%
Value $90.84M Shares 1,050,000 Share Price $86.51 Est. Cost/Share — Unrealized @ Report Date —
— PLAYA HOTELS & RESORTS NV 0.5%
Value $89.22M Shares 14,994,867 Share Price $5.95 Est. Cost/Share — Unrealized @ Report Date —
— LUFAX HOLDING LTD 0.5%
Value $76.08M Shares 5,357,750 Share Price $14.20 Est. Cost/Share — Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.4%
Value $74.73M Shares 1,775,000 Share Price $42.10 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.4%
Value $73.14M Shares 7,170,213 Share Price $10.20 Est. Cost/Share — Unrealized @ Report Date —
— KANSAS CITY SOUTHERN 0.4%
Value $72.34M Shares 354,400 Share Price $204.13 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.4%
Value $71.76M Shares 81,762,000 Share Price $0.88 Est. Cost/Share — Unrealized @ Report Date —
EFX EQUIFAX INC 0.4%
Value $71.48M Shares 370,684 Share Price $192.84 Est. Cost/Share — Unrealized @ Report Date —
— KARUNA THERAPEUTICS INC 0.4%
Value $71.11M Shares 700,000 Share Price $101.59 Est. Cost/Share — Unrealized @ Report Date —
— FIBROGEN INC 0.4%
Value $70.47M Shares 1,900,000 Share Price $37.09 Est. Cost/Share — Unrealized @ Report Date —
BCAB BIOATLA INC 0.4%
Value $66.9M Shares 1,967,060 Share Price $34.01 Est. Cost/Share — Unrealized @ Report Date —
— GENERATION BIO CO 0.4%
Value $64.32M Shares 2,268,819 Share Price $28.35 Est. Cost/Share — Unrealized @ Report Date —
— ARENA PHARMACEUTICALS INC 0.3%
Value $57.62M Shares 750,000 Share Price $76.83 Est. Cost/Share — Unrealized @ Report Date —
PACB PACIFIC BIOSCIENCES CALIF IN 0.3%
Value $54.47M Shares 2,100,000 Share Price $25.94 Est. Cost/Share — Unrealized @ Report Date —
— THERAVANCE BIOPHARMA INC 0.3%
Value $53.81M Shares 56,695,000 Share Price $0.95 Est. Cost/Share — Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.3%
Value $49.87M Shares 2,400,000 Share Price $20.78 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.3%
Value $48.89M Shares 2,425,000 Share Price $20.16 Est. Cost/Share — Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 0.3%
Value $45.49M Shares 350,000 Share Price $129.97 Est. Cost/Share — Unrealized @ Report Date —
— ZOGENIX INC 0.3%
Value $44.98M Shares 2,250,000 Share Price $19.99 Est. Cost/Share — Unrealized @ Report Date —
— CORELOGIC INC 0.3%
Value $44.38M Shares 574,028 Share Price $77.32 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.3%
Value $43.53M Shares 35,000,000 Share Price $1.24 Est. Cost/Share — Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 0.3%
Value $43.33M Shares 1,000,000 Share Price $43.33 Est. Cost/Share — Unrealized @ Report Date —
IONS IONIS PHARMACEUTICALS INC 0.3%
Value $42.41M Shares 750,000 Share Price $56.54 Est. Cost/Share — Unrealized @ Report Date —
ANNX ANNEXON INC 0.2%
Value $38.98M Shares 1,557,261 Share Price $25.03 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.2%
Value $37.64M Shares 2,107,400 Share Price $17.86 Est. Cost/Share — Unrealized @ Report Date —
— CARA THERAPEUTICS INC 0.2%
Value $37.3M Shares 2,465,000 Share Price $15.13 Est. Cost/Share — Unrealized @ Report Date —
— INSMED INC 0.2%
Value $36.55M Shares 32,500,000 Share Price $1.12 Est. Cost/Share — Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 0.2%
Value $36.08M Shares 51,910,000 Share Price $0.69 Est. Cost/Share — Unrealized @ Report Date —
LNTH LANTHEUS HLDGS INC 0.2%
Value $35.75M Shares 2,650,000 Share Price $13.49 Est. Cost/Share — Unrealized @ Report Date —
— ZYMEWORKS INC 0.2%
Value $35.45M Shares 750,000 Share Price $47.26 Est. Cost/Share — Unrealized @ Report Date —
KRYS KRYSTAL BIOTECH INC 0.2%
Value $31.5M Shares 525,000 Share Price $60.00 Est. Cost/Share — Unrealized @ Report Date —
NVAX NOVAVAX INC 0.2%
Value $30.66M Shares 275,000 Share Price $111.51 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.2%
Value $29.89M Shares 29,689,000 Share Price $1.01 Est. Cost/Share — Unrealized @ Report Date —
— PANACEA ACQUISITION CORP 0.2%
Value $29.25M Shares 2,500,000 Share Price $11.70 Est. Cost/Share — Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 0.2%
Value $28.86M Shares 1,250,000 Share Price $23.09 Est. Cost/Share — Unrealized @ Report Date —
— CLEVER LEAVES HOLDINGS INC 0.2%
Value $28.73M Shares 2,478,079 Share Price $11.59 Est. Cost/Share — Unrealized @ Report Date —
DMTKQ DERMTECH INC 0.2%
Value $27.93M Shares 861,090 Share Price $32.44 Est. Cost/Share — Unrealized @ Report Date —
BIIB BIOGEN INC 0.2%
Value $25.22M Shares 103,000 Share Price $244.86 Est. Cost/Share — Unrealized @ Report Date —
— CONSTELLATION PHARMCETICLS I 0.1%
Value $21.6M Shares 750,000 Share Price $28.80 Est. Cost/Share — Unrealized @ Report Date —
BEKE KE HLDGS INC 0.1%
Value $21.11M Shares 343,000 Share Price $61.54 Est. Cost/Share — Unrealized @ Report Date —
GRFS GRIFOLS S A 0.1%
Value $20.56M Shares 1,115,000 Share Price $18.44 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.1%
Value $20M Shares 20,000,000 Share Price $1.00 Est. Cost/Share — Unrealized @ Report Date —
— ZEALAND PHARMA A/S 0.1%
Value $18.33M Shares 510,000 Share Price $35.94 Est. Cost/Share — Unrealized @ Report Date —
ATTOF ATENTO S A 0.1%
Value $18.23M Shares 2,230,357 Share Price $8.17 Est. Cost/Share — Unrealized @ Report Date —
PLRX PLIANT THERAPEUTICS INC 0.1%
Value $17.36M Shares 764,262 Share Price $22.72 Est. Cost/Share — Unrealized @ Report Date —
— DECIPHERA PHARMACEUTICALS IN 0.1%
Value $17.12M Shares 300,000 Share Price $57.07 Est. Cost/Share — Unrealized @ Report Date —
— INHIBRX INC 0.1%
Value $16.82M Shares 510,000 Share Price $32.97 Est. Cost/Share — Unrealized @ Report Date —
RC READY CAPITAL CORP 0.1%
Value $16.81M Shares 1,350,226 Share Price $12.45 Est. Cost/Share — Unrealized @ Report Date —
— ADVERUM BIOTECHNOLOGIES INC 0.1%
Value $16.26M Shares 1,500,000 Share Price $10.84 Est. Cost/Share — Unrealized @ Report Date —
BMY BRISTOL-MYERS SQUIBB CO 0.1%
Value $15.51M Shares 250,000 Share Price $62.03 Est. Cost/Share — Unrealized @ Report Date —
— BRISTOL-MYERS SQUIBB CO 0.1%
Value $14.77M Shares 21,400,000 Share Price $0.69 Est. Cost/Share — Unrealized @ Report Date —
— PRAXIS PRECISION MEDICINES I 0.1%
Value $13.76M Shares 250,000 Share Price $55.02 Est. Cost/Share — Unrealized @ Report Date —
XPO XPO LOGISTICS INC 0.1%
Value $13.11M Shares 110,000 Share Price $119.20 Est. Cost/Share — Unrealized @ Report Date —
— NUANCE COMMUNICATIONS INC 0.1%
Value $13.05M Shares 7,000,000 Share Price $1.86 Est. Cost/Share — Unrealized @ Report Date —
NTLA INTELLIA THERAPEUTICS INC 0.1%
Value $12.24M Shares 225,000 Share Price $54.40 Est. Cost/Share — Unrealized @ Report Date —
— TIGA ACQUISITION CORP 0.1%
Value $11.43M Shares 1,080,000 Share Price $10.58 Est. Cost/Share — Unrealized @ Report Date —
— AVROBIO INC 0.1%
Value $11.08M Shares 795,000 Share Price $13.94 Est. Cost/Share — Unrealized @ Report Date —
RCKT ROCKET PHARMACEUTICALS INC 0.1%
Value $10.97M Shares 200,000 Share Price $54.84 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 0.1%
Value $10.84M Shares 300,000 Share Price $36.13 Est. Cost/Share — Unrealized @ Report Date —
— CASCADE ACQUISITION CORP 0.1%
Value $10.35M Shares 990,000 Share Price $10.45 Est. Cost/Share — Unrealized @ Report Date —
— KINNATE BIOPHARMA INC 0.1%
Value $9.945M Shares 250,000 Share Price $39.78 Est. Cost/Share — Unrealized @ Report Date —
— ALBIREO PHARMA INC 0.1%
Value $9.378M Shares 250,000 Share Price $37.51 Est. Cost/Share — Unrealized @ Report Date —
— SURFACE ONCOLOGY INC 0.1%
Value $9.24M Shares 1,000,000 Share Price $9.24 Est. Cost/Share — Unrealized @ Report Date —
— GOSSAMER BIO INC 0.1%
Value $9.032M Shares 10,000,000 Share Price $0.90 Est. Cost/Share — Unrealized @ Report Date —
— ACACIA COMMUNICATIONS INC 0.0%
Value $7.296M Shares 100,000 Share Price $72.96 Est. Cost/Share — Unrealized @ Report Date —
— FIVE PRIME THERAPEUTICS INC 0.0%
Value $6.804M Shares 400,000 Share Price $17.01 Est. Cost/Share — Unrealized @ Report Date —
COGT COGENT BIOSCIENCES INC 0.0%
Value $6.738M Shares 600,000 Share Price $11.23 Est. Cost/Share — Unrealized @ Report Date —
— IMMUNOGEN INC 0.0%
Value $6.45M Shares 1,000,000 Share Price $6.45 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.0%
Value $5.995M Shares 6,783,000 Share Price $0.88 Est. Cost/Share — Unrealized @ Report Date —
— MARVELL TECHNOLOGY GROUP LTD 0.0%
Value $5.943M Shares 125,000 Share Price $47.54 Est. Cost/Share — Unrealized @ Report Date —
— CURIS INC 0.0%
Value $5.938M Shares 725,000 Share Price $8.19 Est. Cost/Share — Unrealized @ Report Date —
— APELLIS PHARMACEUTICALS INC 0.0%
Value $5.93M Shares 3,522,000 Share Price $1.68 Est. Cost/Share — Unrealized @ Report Date —
STTK SHATTUCK LABS INC 0.0%
Value $5.241M Shares 100,000 Share Price $52.41 Est. Cost/Share — Unrealized @ Report Date —
— IVERIC BIO INC 0.0%
Value $5.215M Shares 754,740 Share Price $6.91 Est. Cost/Share — Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.0%
Value $5.202M Shares 100,000 Share Price $52.02 Est. Cost/Share — Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS IN 0.0%
Value $5.187M Shares 67,600 Share Price $76.73 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 0.0%
Value $5.12M Shares 4,452,086 Share Price $1.15 Est. Cost/Share — Unrealized @ Report Date —
— HUMANCO ACQUISITION CORP 0.0%
Value $4.408M Shares 400,000 Share Price $11.02 Est. Cost/Share — Unrealized @ Report Date —
MASS 908 DEVICES INC 0.0%
Value $4.271M Shares 75,000 Share Price $56.95 Est. Cost/Share — Unrealized @ Report Date —
FDMT 4D MOLECULAR THERAPEUTICS IN 0.0%
Value $4.145M Shares 100,000 Share Price $41.45 Est. Cost/Share — Unrealized @ Report Date —
KURA KURA ONCOLOGY INC 0.0%
Value $4.083M Shares 125,000 Share Price $32.66 Est. Cost/Share — Unrealized @ Report Date —
EQ EQUILLIUM INC 0.0%
Value $3.745M Shares 700,000 Share Price $5.35 Est. Cost/Share — Unrealized @ Report Date —
— ISIS PHARMACEUTICALS INC DEL 0.0%
Value $2.733M Shares 2,500,000 Share Price $1.09 Est. Cost/Share — Unrealized @ Report Date —
— ALPINE IMMUNE SCIENCES INC 0.0%
Value $2.52M Shares 200,000 Share Price $12.60 Est. Cost/Share — Unrealized @ Report Date —
IVA INVENTIVA SA 0.0%
Value $2.32M Shares 160,000 Share Price $14.50 Est. Cost/Share — Unrealized @ Report Date —
SPRY SILVERBACK THERAPEUTICS INC 0.0%
Value $2.207M Shares 47,620 Share Price $46.35 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.0%
Value $1.937M Shares 7,174,613 Share Price $0.27 Est. Cost/Share — Unrealized @ Report Date —
— GOL LINHAS AEREAS INTELIGENT 0.0%
Value $843K Shares 85,838 Share Price $9.82 Est. Cost/Share — Unrealized @ Report Date —
— CEREVEL THERAPEUTICS HLDNG I 0.0%
Value $758K Shares 134,175 Share Price $5.65 Est. Cost/Share — Unrealized @ Report Date —